SMITHTOWN, N.Y., August 23, 2018 (Globe Newswire) iGambit, Inc. (OTCBB: IGMB) is pleased to announce the company has signed an exclusive contract with Device Distributors, LLC, to expand its health monitoring and reporting system into Brazil, Argentina, and throughout South and Central America.
Device Distributors will represent iGambit subsidiary HealthDatix in the territory to facilitate the introduction of cloud data and trend data tracking, reporting, and analysis systems supported by HealthDatix’s wearable medical monitor, the BioDatix Health Band.
The BioDatix Health Band offers round-the-clock monitoring, passively collecting data on heart rate, blood pressure, blood oxygen, sleep, and steps/distance/calories, without affecting the patient’s routine. The device delivers accurate, real-time syncing of data to the HealthDatix platform for use by the client’s Care Team of Professionals, Caregivers, Physicians and their staffs, and is also designed to reduce the time from a BioDatix Health Band wearer’s medical incident to the application of often lifesaving treatments.
BioDatix Health Band transmits data to an FDA certified back-end application, to produce trend reports and alerts. Identified, “out of limit” or “unusual” baselines, can be reported by HealthDatix to the client’s Care Team. The Care Team professionals can receive alerts and send messages to any or all of the Wearer, Caregiver, Physicians, and Physicians’ staff to facilitate better user engagement in managing their overall health.
Our new enhanced health monitoring Health Band offers strategic synergies in multiple markets, e.g. health care management, chronic health conditions, fitness, reducing costs in employee wellness programs and self-insured companies, private self-monitoring, and importantly the continuous real time monitoring of an employee’s health who performs work which has the potential for a major disaster e.g. train conductors, airplane pilots, truck drivers, etc.
The global wearable medical devices market size was valued at USD 3.9 billion in 2014 and is expected to grow with a compound annual growth rate (CAGR) of 28% over the forecast period. Increasing demand for technologically advanced wearable medical devices, rising awareness regarding physical fitness, advent of new smartphone-linked healthcare applications, and growing demand for wireless connectivity in the healthcare industry are the key factors propelling the overall industry.
John Salerno, Chairman of iGambit stated: This partnership is an important step that will expand the market reach of HealthDatix, and create additional value for our customers and our stockholders. Device Distributors will provide the infrastructure to address the particular needs of institutional, legal, and logistic challenges in Brazil, Argentina, and throughout South and Central America.
The achievement of longer healthy lives for the population at large is our mission. Within any population there are some that are apparently healthy and some that are at risk. Consistent with our mission, we aggregate data and deliver accurate Information to a care giver who must make vital decisions on a course of treatment for those at risk. Just as importantly however, is that the health data we collect from the apparently healthy group is compiled into historical data reports available to an attending physician during a client’s office visit or telephone conference. The Caregiver for both the “at risk” and “apparently healthy” populations will no longer only have available a snapshot of health monitoring readings during an office visit which can be misleading at best but also a patients’ vital signs over the course of a desired period of time.
We are also helping to shape the future of our nation’s health care system with robust leveraging of technology that enhances our ability to deliver value based healthcare to all populations without employing additional staff or additional burdens on the Caregivers. Our proprietary data analytics management facilitates the conducting of, and fully utilizing, the new opportunities inherent in the Wellness Visit program. For more information regarding the Wellness Visits and 24/7/365 monitoring of clients with chronic conditions, please visit www.healthdatix.com
About Device Distributors, LLC
Device Distributors brings new technologies and data systems to business and institutional customers in Brazil, Argentina and throughout South and Central America. The company buys, brokers, and provides logistics, customs, and licensing support to enable clients to take advantage of cloud innovations, revolutionary medical devices, and consumer electronics that promote health and fitness. For more information, please visit www.devicedistributors.com.
iGambit (OTCBB: IGMB) is a fully reporting publicly-held company. For more information, please visit www.igambit.com. Information on our web site does not comprise a part of this press release.
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Federal Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intends," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, including but not limited to, economic conditions, dependence on management, dilution to shareholders, lack of capital changes in laws or regulations, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth, demand for products and services of the Company, newly developing technologies, its ability to compete, conflicts of interest related to party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition, and the ability of the Company to obtain additional financing. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.